Fledgling Danish development firm prepares launch of diagnostic instrument  

Danish fledgling company Atonomics is preparing for the launch of a product it has been developing over the past 5 years
Danish fledgling company Atonomics, a point-of-care diagnostic company, is preparing for the launch of a product it has been developing over the past 5 years, writes financial daily newspaper Børsen. The Atolyzer is a mobile phone-sized piece of instrument that from a single drop of blood from a fingertip can detect a range of diseases within 15 minutes. The product offers the same analytical sensitivity and comparable performance as the large central laboratory instruments.
Peter Warthoe, founder and chief scientific officer of Atonomics told Børsen that if everything goes according to plan Atolyzer will be introduced on the Japanese market in one year. "Initially the target group is medical clinics and small hospital wards. But it is our objective to get the apparatus out to patients in their homes during three to four years. The trend is that self-diagnosing is gaining more and more ground."
Development costs so far amount to DKK 100m (USD 17.2m) , of which venture investors have put DKK 97m (USD 16.7m) into the project. The largest investor is Switzerland's Inventages Venture Capital, which owns almost half of Atonomics. Other investors include Sunstone Capital, Neurosearch, Denmark Founders and Murata Manufacturing Co.Ltd.
"We are in the last phase of the development process before Atolyzer is ready for the Japanese market. Our first test is a BNP* cardiac test that can diagnose various heart diseases and measure whether e.g. the heart is strained," says Warthoe.
Atonomics is currently in dialogue with several large international companies, which have the capacity to launch Atolyzer worldwide.
"It has never been the plan that we would handle sales and marketing of the product ourselves. Our dream is to remain a small development company. We already have several new ideas on the drawing board including an allergy test, which requires that you can measure several components at the same time, and a genetic test to measure DNA," says Warthoe.
* A brain natriuretic peptide (BNP) test measures the amount of BNP hormone in the blood. BNP is made by the heart and indicates how well it is working. (source: WebMD).
Link > Atonomics   

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×